Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

Clinical Transplantation

Volumn 19, Issue 5, 2005, Pages 591-599

  Duclos Vallée, Jean Charles ^a,d   Yilmaz, Funda ^a,d   Johanet, Catherine ^b   Roque Alfonso, Anne Marie ^a,d   Gigou, Michelle ^a,d   Trichet, Catherine ^c   Féray, Cyrille ^a   Ballot, Eric ^b   Dussaix, Elisabeth ^a,d   Castaing, Denis ^a,d   Bismuth, Henri ^a,d   Samuel, Didier ^a,d   Guettier, Catherine ^a,d  

^a HÔPITAL PAUL BROUSSE   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Autoimmune liver disease; Cryptogenic cirrhosis; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN GLUCURONIDE; BLOOD CLOTTING FACTOR 5; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; AUTOIMMUNE DISEASE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FATTY LIVER; FEMALE; GRAFT INFECTION; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK FACTOR; SCORING SYSTEM; VEIN DISEASE; VIROLOGY;

ADOLESCENT; ADULT; AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 25144512547     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00323.x     Document Type: Review

References (28)

1. Saunders JB, Walters JR, Davies AP, Paton A. A twenty year prospective study of cirrhosis. BMJ 1981: 282: 263.
2. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol 1994: 89: 1836.
3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999: 29: 664.
4. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000: 32: 689.
5. Ayata G, Gordon FD, Lewis WD et al. Cryptogenic cirrhosis; clinicopathologic findings at and after liver transplantation. Hum Pathol 2002: 33: 1098.
6. Berg T, Neuhaus R, Klein R et al. Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT. Transplantation 2002: 74: 792.
7. Roitt M, Doniach D. Immunofluorescent test for the detection of antibodies. In: WHO Booklet of Immunological Studies. Geneva, Switzerland: World Health Organization, 1972: 1.
8. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999: 31: 929.
9. Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis. J Hepatol 2000: 33: 208.
10. Sciot R, Staessen D, Van Damme B et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988: 13: 593.
11. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998: 15: 246.
12. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995: 22: 696.
13. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997: 25: 658.
14. International Panel. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000: 31: 792.
15. Duclos-Vallée JC, Sebagh M, Rifai K et al. A ten-year follow-up study of patients transplanted for autoimmune hepatitis: histologic recurrence precedes clinical and biochemical recurrence. Gut 2003: 52: 893.
16. Kerkar N, Hadzic N, Davies ET et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998: 351: 409.
17. Heneghan MA, Portmann BC, Norris SM et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001: 34: 464.
18. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002: 36: 150.
19. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of non alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002: 123: 134.
20. Charlton M, Kasparova P, Weston S et al. Frequency of non-alcoholic steatohepatitis as a cause of advance liver disease. Liver Transplant 2001: 7: 608.
21. Struben VM, Hespenheide EE, Caldwell SH. Non alcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000: 108: 9.
22. Ong J, Younossi ZM, Reddy V et al. Cryptogenic cirrhosis and posttransplantation non alcoholic fatty liver disease. Liver Transplant 2001: 7: 797.
23. Contos MJ, Cales W, Sterling RK et al. Development of non alcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transplant 2001: 7: 363.
24. Nevens F, Staessen D, Sciot R et al. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994: 106: 459.
25. Bernard PH, Le Bail B, Cransac M et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol 1995: 22: 495.
26. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote J, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995: 21: 1238.
27. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000: 124: 1599.
28. Wanless IR. Vascular disorders. In: Macsween RN, Burt AD, Anthony PP, Ishak KG, Portmann BC eds. Pathology of the Liver. London, UK: Churchill Livingstone, 2001: 539.